About the bill
- Full Title
A bill to reduce disparities and improve access to effective and cost efficient diagnosis and treatment of prostate cancer through advances in testing, research, and education, including through telehealth, comparative effectiveness research, and identification of best practices in patient education and outreach particularly with respect to underserved racial, ethnic and rural populations and men with a family history of prostate cancer, to establish a directive on what constitutes clinically appropriate prostate cancer imaging, and to create a prostate cancer scientific advisory board for the Office of the Chief Scientist at the Food and Drug Administration to accelerate real-time sharing of the latest research and accelerate movement of new medicines to patients.
The bill’s title was written by its sponsor.
Earlier Version — Introduced
This activity took place on a related bill, S. 1190 (112th).
This is the first step in the legislative process.
3 cosponsors (3R) (show)
- Committee Assignments
The committee chair determines whether a bill will move past the committee stage.
There have been no roll call votes related to this bill.
- Subject Areas
Links & tools
Click a format for a citation suggestion:
Civic Impulse. (2016). S. 516 — 113th Congress: PROSTATE Act. Retrieved from https://www.govtrack.us/congress/bills/113/s516
“S. 516 — 113th Congress: PROSTATE Act.” www.GovTrack.us. 2013. May 3, 2016 <https://www.govtrack.us/congress/bills/113/s516>
|title=S. 516 (113th)
|accessdate=May 3, 2016
|author=113th Congress (2013)
|date=March 11, 2013